Michael James O'halloran, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1312 Cummings Ave, Eau Claire, WI 54701 Phone: 715-835-2388 |
Dr. Michael J Smith, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 714 W Hamilton Ave, Eau Claire, WI 54701 Phone: 715-830-9990 Fax: 715-830-9995 |
Madalina L Mindrut, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3212 Stein Blvd, Eau Claire, WI 54710 Phone: 715-830-0732 |
Ganesh Kumar Namachivayam, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 |
Dusan Petar Markovic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2116 Craig Rd, Eau Claire, WI 54701 Phone: 715-858-4500 |
News Archive
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
Most cases of gastrointestinal stromal tumor (GIST), a type of soft-tissue cancer (sarcoma), are caused by mutations in genes that can be effectively targeted with drugs that inhibit the activity of rogue cancer-promoting enzymes.
Most of the debate around e-cigarettes has focused on the developed world, but the devices are becoming more widely available in some low- and middle-income countries, where there is even greater potential for impact on public health, say two Stanford University School of Medicine researchers.
MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.
› Verified 6 days ago